发明名称 THERAPY-ENHANCING GLUCAN
摘要 This invention provides a method for introducing substances into cells comprising contacting a composition comprising orally administered beta-glucan with said cells. This invention also provides a method for introducing substances into a subject comprising administering to the subject an effective amount of the above compositions. The substance which could be delivered orally includes but is not limited to peptides, proteins, RNAs, DNAs, chemotherapeutic agents, biologically active agents, plasmids, and other small molecules and compounds. Finally, this invention provides a composition comprising orally administered beta-glucan capable of enhancing efficacy of IgM and different uses of the said composition.
申请公布号 US2013183295(A1) 申请公布日期 2013.07.18
申请号 US201313760307 申请日期 2013.02.06
申请人 SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH;BIOTEC PHARMACON ASA;BIOTEC PHARMACON ASA;SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 发明人 CHEUNG NAI-KONG V.;ENGSTAD ROLF EINAR
分类号 A61K31/716;A61K31/715;A61K31/739;A61K39/395;A61K39/44 主分类号 A61K31/716
代理机构 代理人
主权项
地址